Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Research brief

Review: Oncoviruses linking ageing hallmarks and cancer signalling

This review abstract describes how oncoviruses such as HPV, Epstein-Barr virus, hepatitis B and C viruses and Kaposi's sarcoma-associated herpesvirus are reported to reprogramme host signalling, connecting hallmarks of ageing with cancer. It is a synthesis of current knowledge, not new experimental data. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The abstract states that oncoviruses cause a substantial fraction of human cancers and modulate host pathways that also govern ageing. [1]

  2. Viral proteins frequently target p53, mTOR, NF-κB, PI3K/AKT and Wnt/β-catenin, which the abstract links to dysregulated survival, proliferation and senescence. [1]

  3. The review is said to discuss virus-induced changes to the tumour microenvironment and immune responses in the interplay of ageing and cancer. [1]

The source at a glance

Study type / format
Narrative review (abstract only)
Population / context
Human cancers and host cells discussed in a review of oncoviruses, ageing and cancer
Summary based on
Study abstract
Original publication
September 1, 2026

Shared mechanisms of oncoviruses, ageing and cancer

The abstract states that oncoviruses cause a substantial fraction of human cancers and act as modulators of host cellular pathways that also govern ageing. It names shared molecular mechanisms: genomic instability, epigenetic alterations, telomere attrition and chronic inflammation. The review focuses on how these viruses intersect with hallmarks of ageing and cancer.

Supporting source [1]

Viral targeting of p53, mTOR, NF-κB and other pathways

According to the abstract, viral proteins frequently target central pathways including p53, mTOR, NF-κB, PI3K/AKT and Wnt/β-catenin. This is described as leading to dysregulated cell survival, proliferation and senescence. The text says these interactions facilitate tumourigenesis and also accelerate ageing-associated cellular dysfunctions such as immunosenescence and inflammaging.

Supporting source [1]

Tumour microenvironment and immune response in the review

The abstract says the review also discusses how virus-induced modulation of the tumour microenvironment and host immune responses contributes to the interplay between ageing and cancer. It frames oncoviruses as having a dual role, as drivers of both age-related decline and cancer development, and suggests these mechanisms may point to therapeutic targets and prevention strategies in ageing populations.

Supporting source [1]

How to interpret this

This is an abstract only; the full text was not reviewed. It is a narrative synthesis of current knowledge, not a new study, and the abstract reports no sample, follow-up, effect sizes or quantified uncertainty. Statements about accelerated ageing-associated dysfunction and about possible therapeutic targets are described as interpretations and prospects, not demonstrated human outcomes.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Oncoviruses at the Crossroads of Ageing and Cancer: Molecular Mechanisms and Key Signalling Pathways.

Allehyani N, Alissa M, Alghamdi A, Alshehri MA, Abusalim GS, Juraybi TN, Alsuwat MA, Safhi AY. · europepmc.org · September 1, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    responsible for a substantial fraction of human
  2. Finding 2 ↑

    frequently targeted by viral proteins
  3. Finding 3 ↑

    virus-induced modulation of the tumour microenvironment

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…